Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 21, 2021

View Archived Issues

FDG-PET signal is substantially affected by microglial glucose uptake in neurodegenerative diseases

New spondyloarthritis therapeutic target identified

Elevated plasma CXCL16 levels found in severe COVID-19 patients

LRFN1 gene as a possible cause of autism spectrum disorder

Discovery of broad-spectrum inhibitor of oncogenic BRAF dimerization

Role of de novo mutations in severe male infertility

Hutchison MediPharma patents new CSF1R inhibitors

Chinese researchers disclose new ROS inhibitors

Whole exome sequencing analysis identifies novel genes associated with osteoarthritis

Angiex presents new TM4SF1-targeting PROTACs

Dongguan Hec New Drug Research and Development synthesizes new HBV antivirals

Medshine Discovery describes new compounds for cancer

Alu RNA induces retinal pigment epithelium degeneration in geographic atrophy via the inflammasome

Mitochondrial augmentation: a promising disease-modifying strategy for mitochondrial DNA disorders

NPAS3 identified as a risk gene for autism spectrum disorder

Tango Therapeutics' MTAPnull PRMT5 inhibitor TNG-908 active in multiple xenograft tumor models

HLA fine mapping identifies INPP5A as a risk gene for tuberculosis

Oncodesign and TiumBio collaborate to discover and develop candidates for fibrosis

Mablink and Emergence enter licensing agreement for ADC targeting Nectin-4

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...